FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Faeth Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.44+0.64 (+3.40%)
Close on Oct 19, 2026
- Market cap
- $109.70M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$22.29MFY2025